The effectiveness of high-dose adjunctive corticosteroid therapy in HIV-negative patients with Pneumocystis jirovecii pneumonia

Read full text
Authors: Ling Wang, Zi Ning Tan, Yuqian Fan, Zhenfa Wang, Zheng Wang, Huaqin Pan, Guqin Zhang
Cited by: 1

Abstract

Background: pneumonia (PJP) who present with respiratory failure is increasing. However, the optimal dosing regimen remains uncertain. Our study aimed to evaluate the effectiveness of high-dose versus low-dose adjunctive corticosteroid therapy in this population. Methods: This retrospective cohort study included HIV-negative patients diagnosed with PJP who received adjunctive corticosteroid therapy in Zhongnan Hospital of Wuhan University from June 2018 to March 2023. Patients were categorized into high-dose group (≥1 mg/kg/day of prednisone equivalent) and low-dose group (

Fields of Study & Subjects

Pneumocystis jirovecii pneumonia detection and treatment Pneumonia and Respiratory Infections Infectious Diseases and Tuberculosis

Publication details

Journal / source
Journal of Thoracic Disease
Publisher
AME Publishing Company
Volume
18
Issue
1
Pages
16–16
Publication date
1 January 2026
Language
EN